Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | TYR | P14679 | 1/20 | 0.35 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
| ▸ | CASP6 | P55212 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.34 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7972364 | 0.96 | MAOB (0.41) | MAOBKDM4ETYRDAOCASP6 | |
| SCHEMBL4582881 | 0.82 | MAOB (0.47) | MAOBKDM4ETYRDAOCASP6 | |
| SCHEMBL9306755 | 0.74 | — | — | |
| SCHEMBL4651248 | 0.71 | — | — | |
| SCHEMBL19386685 | 0.69 | L3MBTL1 (0.36) | — | |
| SCHEMBL13053707 | 0.64 | — | — | |
| SCHEMBL18432096 | 0.64 | — | — | |
| SCHEMBL17325742 | 0.64 | — | — | |
| SCHEMBL173206 | 0.64 | — | — | |
| SCHEMBL16921616 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996036333-A1 | METHODS FOR INHIBITING BONE LOSS | ELI LILLY AND COMPANY (US) | 1996-11-21 | — | — | WO | disclosed |
| EP-0743065-A2 | Vanadium compounds for inhibiting bone loss | ELI LILLY AND COMPANY (US) | 1996-11-20 | — | — | EP | disclosed |
| US-5545661-A | TREATING POSTMENOPAUSAL OR SENILE OSTEOPOROSIS | ELI LILLY AND COMPANY (US) | 1996-08-13 | — | — | US | disclosed |